Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Eva Astrid Operskalski, PhD

    TitleAssociate Professor of Research Pediatrics
    SchoolKeck School of Medicine of USC
    DepartmentPediatrics
    AddressHRA 300 1640 Marengo
    Off Campus
    Los Angeles California 90089-9300
    Phone+1 323 865 1554
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Dr. Operskalski is Director of Clinical Research at the MCA Center and has over 25 years experience co-directing or managing complex multi-center investigations of factors that influence HIV and hepatitis B and C disease occurrence and outcome. Since joining MCA she has coordinated the numerous clinical research studies carried out by the program, including studies of the Pediatric AIDS Clinical Trials Group (PACTG), which is now the International Maternal Pediatric Adolescent Center Trials (IMPAACT) Group, other NIH-funded studies, and MCA's own investigator-initiated studies. The studies include therapeutic trials for HIV and other infectious diseases, vaccine studies, and observational studies of long-term outcomes of disease and therapy. She has participated in the development of collaborative activities related to maternal child and adolescent infectious disease prevention and treatment, including successful grant proposals to the national Health Resources and Services Administration to expand MCA’s coordinated clinical services and access to research for women, infants, children, and youth. Dr. Operskalski's research focus has been the epidemiology of HIV, HCV, and other transfusion-transmitted infections; specifically, factors that influence progression from infection to disease (including the effect of interactions of HIV, HTLV, HBV, HCV, EBV, CMV on progression and transmission of each) and factors that influence transmission by blood transfusion, and heterosexual and household contact. She was Principal Investigator for a clinic-based HIV vaccine preparedness (VPS) pilot study, sponsored by the PACTG, to investigate whether network analysis can be used to establish clinic-based cohorts of adolescents for HIV vaccine preparedness activities and vaccine trials. The VPS brought together a multi-disciplinary team of investigators from the KSOM Departments of Pediatrics and Preventive Medicine, as well as from Johns Hopkins University School of Public Health, and the Desmond Tutu HIV Centre in Cape Town and the Perinatal HIV Research Unit in Johannesburg, South Africa. These investigators have extensive experience and expertise in public health, epidemiology, prevention, social network mapping, and clinical research.


      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Spencer LY, Christiansen S, Wang CH, Mack WJ, Young M, Strickler HD, Anastos K, Minkoff H, Cohen M, Geenblatt RM, Karim R, Operskalski E, Frederick T, Homans JD, Landay A, Kovacs A. Systemic Immune Activation and HIV Shedding in the Female Genital Tract. J Acquir Immune Defic Syndr. 2016 Feb 01; 71(2):155-62. PMID: 26334738; PMCID: PMC4712091 [Available on 02/01/17].
      2. Kerzerho J, McIlvaine EJ, Anthony P, Mack WJ, Wang CH, Frederick T, Operskalski E, Chen Z, Al-Harthi L, Landay A, Young MA, Tien PC, Augenbraun M, Strickler HD, Akbari O, Golub ET, Sharp GB, Kovacs A. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women. J Acquir Immune Defic Syndr. 2016 Feb 01; 71(2):172-80. PMID: 26761519; PMCID: PMC4712709 [Available on 02/01/17].
      3. Jackman RP, Deng X, Bolgiano D, Utter GH, Schechterly C, Lebedeva M, Operskalski E, Luban NL, Alter H, Busch MP, Slichter SJ, Norris PJ. Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response. Transfusion. 2014 Mar; 54(3):672-80. PMID: 23808544; PMCID: PMC3825847.
      4. Karim R, Mack WJ, Stiller T, Operskalski E, Frederick T, Landay A, Young MA, Tien PC, Augenbraun M, Strickler HD, Kovacs A. Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach. AIDS. 2013 Jun 01; 27(9):1473-81. PMID: 23945505; PMCID: PMC3949252.
      5. Wohl AR, Galvan FH, Carlos JA, Myers HF, Garland W, Witt MD, Cadden J, Operskalski E, Jordan W, George S. A comparison of MSM stigma, HIV stigma and depression in HIV-positive Latino and African American men who have sex with men (MSM). AIDS Behav. 2013 May; 17(4):1454-64. PMID: 23247362.
        View in: PubMed
      6. Operskalski E. HHV-8, transfusion, and mortality. J Infect Dis. 2012 Nov 15; 206(10):1485-7. PMID: 22949305.
        View in: PubMed
      7. Frederick T, Homans J, Spencer L, Kramer F, Stek A, Operskalski E, Kovacs A. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants. Clin Infect Dis. 2012 Sep; 55(6):877-84. PMID: 22675157.
        View in: PubMed
      8. Homans J, Christensen S, Stiller T, Wang CH, Mack W, Anastos K, Minkoff H, Young M, Greenblatt R, Cohen M, Strickler H, Karim R, Spencer LY, Operskalski E, Frederick T, Kovacs A. Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding. J Acquir Immune Defic Syndr. 2012 May 01; 60(1):99-110. PMID: 22517416; PMCID: PMC3334315.
      9. Selvarajah S, Keating S, Heitman J, Lu K, Simmons G, Norris PJ, Operskalski E, Mosley JW, Busch MP. Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection. J Gen Virol. 2012 Aug; 93(Pt 8):1673-9. PMID: 22535775; PMCID: PMC3541758.
      10. Wohl AR, Galvan FH, Myers HF, Garland W, George S, Witt M, Cadden J, Operskalski E, Jordan W, Carpio F, Lee ML. Do social support, stress, disclosure and stigma influence retention in HIV care for Latino and African American men who have sex with men and women? AIDS Behav. 2011 Aug; 15(6):1098-110. PMID: 20963630.
        View in: PubMed
      11. Operskalski E, Kovacs A. HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Curr HIV/AIDS Rep. 2011 Mar; 8(1):12-22. PMID: 21221855; PMCID: PMC3035774.
      12. Bernardin F, Operskalski E, Busch M, Delwart E. Transfusion transmission of highly prevalent commensal human viruses. Transfusion. 2010 Nov; 50(11):2474-83. PMID: 20497515.
        View in: PubMed
      13. Wohl AR, Galvan FH, Myers HF, Garland W, George S, Witt M, Cadden J, Operskalski E, Jordan W, Carpio F. Social support, stress and social network characteristics among HIV-positive Latino and African American women and men who have sex with men. AIDS Behav. 2010 Oct; 14(5):1149-58. PMID: 20107888.
        View in: PubMed
      14. Kovacs A, Karim R, Mack WJ, Xu J, Chen Z, Operskalski E, Frederick T, Landay A, Voris J, Spencer LS, Young MA, Tien PC, Augenbraun M, Strickler HD, Al-Harthi L. Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus. J Infect Dis. 2010 Mar 15; 201(6):823-34. PMID: 20151840; PMCID: PMC3105602.
      15. Valente TW, Zogg JB, Christensen S, Richardson J, Kovacs A, Operskalski E. Using social networks to recruit an HIV vaccine preparedness cohort. J Acquir Immune Defic Syndr. 2009 Dec 01; 52(4):514-23. PMID: 19584741; PMCID: PMC2783777.
      16. French AL, Lin MY, Evans CT, Benning L, Glesby MJ, Young MA, Operskalski E, Augenbraun M, Peters M. Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women. Clin Infect Dis. 2009 Jul 01; 49(1):148-54. PMID: 19480573; PMCID: PMC2743413.
      17. Cannon MJ, Operskalski E, Mosley JW, Radford K, Dollard SC. Lack of evidence for human herpesvirus-8 transmission via blood transfusion in a historical US cohort. J Infect Dis. 2009 Jun 01; 199(11):1592-8. PMID: 19385734.
        View in: PubMed
      18. Kapetanovic S, Christensen S, Karim R, Lin F, Mack WJ, Operskalski E, Frederick T, Spencer L, Stek A, Kramer F, Kovacs A. Correlates of perinatal depression in HIV-infected women. AIDS Patient Care STDS. 2009 Feb; 23(2):101-8. PMID: 19196032; PMCID: PMC2856494.
      19. Operskalski E, Mack WJ, Strickler HD, French AL, Augenbraun M, Tien PC, Villacres MC, Spencer LY, Degiacomo M, Kovacs A. Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women. J Clin Virol. 2008 Apr; 41(4):255-63. PMID: 18243785; PMCID: PMC3493623.
      20. Mosley JW, Operskalski E, Tobler LH, Buskell ZJ, Andrews WW, Phelps B, Dockter J, Giachetti C, Seeff LB, Busch MP. The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy. J Viral Hepat. 2008 Feb; 15(2):120-8. PMID: 18184195.
        View in: PubMed
      21. French AL, Operskalski E, Peters M, Strickler HD, Tien PC, Sharp GB, Glesby MJ, Young M, Augenbraun M, Seaberg E, Kovacs A. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. J Infect Dis. 2007 May 15; 195(10):1437-42. PMID: 17436223; PMCID: PMC3133731.
      22. Laskus T, Operskalski E, Radkowski M, Wilkinson J, Mack WJ, deGiacomo M, Al-Harthi L, Chen Z, Xu J, Kovacs A. Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women. J Infect Dis. 2007 Jan 01; 195(1):124-33. PMID: 17152016; PMCID: PMC3319123.
      23. Diaz RS, Pardini R, Catroxo M, Operskalski E, Mosley JW, Busch MP. HIV-1 superinfection is not a common event. J Clin Virol. 2005 Aug; 33(4):328-30. PMID: 16036183.
        View in: PubMed
      24. Mosley JW, Operskalski E, Tobler LH, Andrews WW, Phelps B, Dockter J, Giachetti C, Busch MP. Viral and host factors in early hepatitis C virus infection. Hepatology. 2005 Jul; 42(1):86-92. PMID: 15954090.
        View in: PubMed
      25. Laskus T, Wilkinson J, Gallegos-Orozco JF, Radkowski M, Adair DM, Nowicki M, Operskalski E, Buskell Z, Seeff LB, Vargas H, Rakela J. Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion. Gastroenterology. 2004 Sep; 127(3):764-76. PMID: 15362033.
        View in: PubMed
      26. Operskalski E, Mosley JW, Tobler LH, Fiebig EW, Nowicki MJ, Mimms LT, Gallarda J, Phelps BH, Busch MP. HCV viral load in anti-HCV-reactive donors and infectivity for their recipients. Transfusion. 2003 Oct; 43(10):1433-41. PMID: 14507276.
        View in: PubMed
      27. Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, Martinez OP, Meyer L, Michael NL, Operskalski E, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Stewart GJ, Theodorou ID, Ullum H, Vicenzi E, Vlahov D, Wilkinson D, Workman C, Zagury JF, O'Brien TR. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med. 2001 Nov 06; 135(9):782-95. PMID: 11694103.
        View in: PubMed
      28. de Oliveira CF, Diaz RS, Machado DM, Sullivan MT, Finlayson T, Gwinn M, Lackritz EM, Williams AE, Kessler D, Operskalski E, Mosley JW, Busch MP. Surveillance of HIV-1 genetic subtypesand diversity in the US blood supply. Transfusion. 2000 Nov; 40(11):1399-406. PMID: 11099672.
        View in: PubMed
      29. Diaz RS, De Oliveira CF, Pardini R, Operskalski E, Mayer AJ, Busch MP. HIV type 1 tat gene heteroduplex mobility assay as a tool to establish epidemiologic relationships among HIV type 1-infected individuals. AIDS Res Hum Retroviruses. 1999 Sep 01; 15(13):1151-6. PMID: 10480628.
        View in: PubMed
      30. Wilkinson DA, Operskalski E, Busch MP, Mosley JW, Koup RA. A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness. J Infect Dis. 1998 Oct; 178(4):1163-6. PMID: 9806051.
        View in: PubMed
      31. Operskalski E, Stram DO, Busch MP, Huang W, Harris M, Dietrich SL, Schiff ER, Donegan E, Mosley JW. Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. Am J Epidemiol. 1997 Oct 15; 146(8):655-61. PMID: 9345119.
        View in: PubMed
      32. Operskalski E, Mosley JW, Busch MP, Stram DO. Influences of age, viral load, and CD4+ count on the rate of progression of HIV-1 infection to AIDS. Transfusion Safety Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jul 01; 15(3):243-4. PMID: 9257660.
        View in: PubMed
      33. Operskalski E, Busch MP, Mosley JW, Stram DO. Comparative rates of disease progression among persons infected with the same or different HIV-1 strains. The Transfusion Safety Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 01; 15(2):145-50. PMID: 9241114.
        View in: PubMed
      34. Operskalski E, Busch MP, Mosley JW, Kedes DH. Blood donations and viruses. Lancet. 1997 May 03; 349(9061):1327. PMID: 9142091.
        View in: PubMed
      35. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med. 1996 Aug; 2(8):918-24. PMID: 8705863.
        View in: PubMed
      36. Busch MP, Operskalski E, Mosley JW, Lee TH, Henrard D, Herman S, Sachs DH, Harris M, Huang W, Stram DO. Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group. J Infect Dis. 1996 Jul; 174(1):26-33. PMID: 8656010.
        View in: PubMed
      37. Wong WY, Zhou Y, Operskalski E, Hassett J, Powars DR, Mosley JW. Hematologic profile and lymphocyte subpopulations in hemoglobin SC disease: comparison with hemoglobin SS and black controls. The Transfusion Safety Study Group. Am J Hematol. 1996 Jul; 52(3):150-4. PMID: 8756079.
        View in: PubMed
      38. Operskalski E, Mosley JW. Pooled plasma derivatives and Creutzfeldt-Jakob disease. Lancet. 1995 Nov 04; 346(8984):1224. PMID: 7475673.
        View in: PubMed
      39. Operskalski E, Stram DO, Lee H, Zhou Y, Donegan E, Busch MP, Stevens CE, Schiff ER, Dietrich SL, Mosley JW. Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Study Group. J Infect Dis. 1995 Sep; 172(3):648-55. PMID: 7658055.
        View in: PubMed
      40. Wong WY, Powars DR, Operskalski E, Hassett J, Parker JW, Sarnaik S, Pegelow CH, Hilgartner MW, Johnson CS, Zhou Y. Blood transfusions and immunophenotypic alterations of lymphocyte subsets in sickle cell anemia. The Transfusion Safety Study Group. Blood. 1995 Apr 15; 85(8):2091-7. PMID: 7718880.
        View in: PubMed
      41. Busch MP, Operskalski E, Mosley JW, Stevens CE, Schiff ER, Kleinman SH, Lee H, Lee M, Harris M. Epidemiologic background and long-term course of disease in human immunodeficiency virus type 1-infected blood donors identified before routine laboratory screening. Transfusion Safety Study Group. Transfusion. 1994 Oct; 34(10):858-64. PMID: 7940656.
        View in: PubMed
      42. Donegan E, Lee H, Operskalski E, Shaw GM, Kleinman SH, Busch MP, Stevens CE, Schiff ER, Nowicki MJ, Hollingsworth CG. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion. 1994 Jun; 34(6):478-83. PMID: 8023388.
        View in: PubMed
      43. Busch MP, Valinsky JE, Paglieroni T, Prince HE, Crutcher GJ, Gjerset GF, Operskalski E, Charlebois E, Bianco C, Holland PV. Screening of blood donors for idiopathic CD4+ T-lymphocytopenia. Transfusion. 1994 Mar; 34(3):192-7. PMID: 7908469.
        View in: PubMed
      44. Mosley JW, Nowicki MJ, Kasper CK, Donegan E, Aledort LM, Hilgartner MW, Operskalski E. Hepatitis A virus transmission by blood products in the United States. Transfusion Safety Study Group. Vox Sang. 1994; 67 Suppl 1:24-8. PMID: 8091731.
        View in: PubMed
      45. Hilgartner MW, Buckley JD, Operskalski E, Pike MC, Mosley JW. Purity of factor VIII concentrates and serial CD4 counts. The Transfusion Safety Study Group. Lancet. 1993 May 29; 341(8857):1373-4. PMID: 8098792.
        View in: PubMed
      46. Aledort LM, Operskalski E, Dietrich SL, Koerper MA, Gjerset GF, Lusher JM, Lian EC, Mosley JW. Low CD4+ counts in a study of transfusion safety. The Transfusion Safety Study Group. N Engl J Med. 1993 Feb 11; 328(6):441-2. PMID: 8093638.
        View in: PubMed
      47. Lusher JM, Operskalski E, Aledort LM, Dietrich SL, Gjerset GF, Hilgartner MW, Koerper MA, Pegelow CH, Lee H, Mosley JW. Risk of human immunodeficiency virus type 1 infection among sexual and nonsexual household contacts of persons with congenital clotting disorders. Pediatrics. 1991 Aug; 88(2):242-9. PMID: 1861921.
        View in: PubMed
      48. Donegan E, Stuart M, Niland JC, Sacks HS, Azen SP, Dietrich SL, Faucett C, Fletcher MA, Kleinman SH, Operskalski E. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med. 1990 Nov 15; 113(10):733-9. PMID: 2240875.
        View in: PubMed
      49. Dietrich SL, Mosley JW, Lusher JM, Hilgartner MW, Operskalski E, Habel L, Aledort LM, Gjerset GF, Koerper MA, Lewis BH. Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study Group. Vox Sang. 1990; 59(3):129-35. PMID: 2124751.
        View in: PubMed
      50. Operskalski E, Schiff ER, Kleinman SH, Busch M, Taylor PE, Parks WP, Lee H, Tomasulo PA, Donegan E, Stuart M. Epidemiologic background of blood donors with antibody to human T-cell lymphotropic virus. Transfusion Safety Study Group. Transfusion. 1989 Oct; 29(8):746-8. PMID: 2572078.
        View in: PubMed
      51. Kleinman SH, Niland JC, Azen SP, Operskalski E, Barbosa LH, Chernoff AI, Edwards VM, Lenes BA, Marshall GJ, Nemo GJ. Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor Repository. Transfusion. 1989 Sep; 29(7):572-80. PMID: 2672433.
        View in: PubMed
      52. Operskalski E, Visscher BR, Malmgren RM, Detels R. A case-control study of multiple sclerosis. Neurology. 1989 Jun; 39(6):825-9. PMID: 2725877.
        View in: PubMed
      53. Gjerset GF, Vyas GN, Bhat R, Operskalski E. Phenotypes for group-specific component among patients exposed to human immunodeficiency virus by transfusions. J Infect Dis. 1988 Mar; 157(3):609-10. PMID: 3343536.
        View in: PubMed
      54. Operskalski E, Preston-Martin S, Henderson BE, Visscher BR. A case-control study of osteosarcoma in young persons. Am J Epidemiol. 1987 Jul; 126(1):118-26. PMID: 3473934.
        View in: PubMed
      55. Enstrom JE, Operskalski E. Multiple sclerosis among Spanish-surnamed Californians. Neurology. 1978 May; 28(5):434-8. PMID: 565484.
        View in: PubMed